STUDY. Full-Face Laser Resurfacing Using a Supplemented Topical Anesthesia Protocol
|
|
- Mervin Goodman
- 6 years ago
- Views:
Transcription
1 STUDY Full-Face Laser Resurfacing Using a Supplemented Topical Anesthesia Protocol Suzanne L. Kilmer, MD; Vera Chotzen, MD; Brian D. Zelickson, MD; Marla McClaren, MD; Susan Silva, MD; Jacqueline Calkin, MD; David No, MD, PhD Background: Laser resurfacing has become a popular modality for the treatment of photodamaged skin, rhytids, and acne scarring. In many cases, this procedure is performed under general anesthesia or intravenous sedation in conjunction with nerve blocks and local infiltration. Objective: To evaluate the safety and efficacy of facial carbon dioxide laser resurfacing using a supplemented topical anesthesia protocol. Design: Nonrandomized case series of patients observed for 1 year. Setting: Outpatient surgery center. Patients: Two hundred consecutive patients undergoing treatment for facial rhytids or acne scarring. Intervention: Full-face carbon dioxide laser resurfacing procedures were performed using a supplemented topical anesthesia protocol. Pretreatment medications included diazepam, oral analgesics, and intramuscular ketorolac tromethamine. Main Outcome Measures: Tolerability of procedure, healing times, and adverse effects. Results: Topical anesthesia provided effective and sufficient anesthesia in most cases. Only 10 of 200 patients required additional anesthesia (regional nerve blocks and/or local infiltration). Substantial improvement of rhytids, photodamage, and acne scarring was observed. Posttreatment hypopigmentation was seen in 1 patient. Scarring was not observed. Conclusion: A supplemented topical anesthesia protocol for full-face laser resurfacing is a safe and effective alternative to traditional anesthesia strategies. Arch Dermatol. 2003;139: From the Laser & Skin Surgery Center of Northern California, Sacramento. The authors have no relevant financial interest in this article. CARBON DIOXIDE laser resurfacing of the face is an effective and well-established treatment of rhytids, photodamaged skin, and acne scarring. 1-5 Because this procedure involves removal of the entire epidermis and upper portions of the dermis, carbon dioxide laser resurfacing requires adequate anesthesia to maximize tolerability. Traditionally, general anesthesia or regional nerve blocks (with or without intravenous sedation and regional infiltration) have been used. 6-9 Regional anesthesia of the face has also been used for laser resurfacing While effective and efficient, regional nerve blocks require needle injections causing many patients unwanted discomfort and anxiety. Furthermore, regional nerve blocks often leave skip areas that are deficient in analgesia. Some researchers have advocated the use of tumescent anesthesia as an adjuvant to nerve blocks. 6,14 While effective, tumescent anesthesia often requires multiple needlesticks and may increase the cumulative dose of lidocaine. While this infiltration of dilute lidocaine is unlikely to cause toxic effects, postoperative edema is markedly increased. With the emergence of laser procedures, a corresponding need for topical anesthesia has arisen. The most common of the various preparations, EMLA (a proprietary acronym for eutectic mixture of local anesthetics; AstraZeneca Pharmaceuticals LP, Wilmington, Del), has been used successfully for a variety of procedures, including venipuncture, treatment of molluscum contagiosum, shave biopsies, excisional biopsy, split-thickness skin grafts, and debridement of venous leg ulcers Laser treatments for vascular lesions have also been performed using topical anesthesia. 13,21-24 Previously, there have been a number of studies using erbium:yag laser resurfacing with topical anesthesia alone The results, however, have been mixed, with 1 study showing that most patients required additional anesthetic infiltration While erbium:yag resurfacing is 1279
2 Supplemented Topical Anesthesia Protocol 1. After washing face and placing hot compresses for 10 minutes, patient applies 30 g of EMLA cream to face under occlusion. 2. Ninety minutes later, patient is given 1-2 tablets of 5-mg hydrocodone/500-mg acetaminophen po, 5-10 mg of diazepam po, and/or mg of ketorolac IM. An additional 30 g of EMLA cream is applied under occlusion. Anatomic areas are covered with individual pieces of plastic wrap. Special care is taken to avoid any skip areas. 3. Forty-five to 60 minutes later, laser resurfacing is performed. Plastic wrap from 1 area is removed, and the EMLA cream is wiped with dry gauze immediately prior to treatment. When possible, repeat passes are performed on same area before moving to the next quadrant. Abbreviations: EMLA, eutectic mixture of local anesthetics; IM, intramuscularly; po, by mouth. more superficial, carbon dioxide resurfacing produces deeper thermal injury, presenting a greater challenge for adequate pain control. We report here the use of EMLA in a supplemented topical anesthesia protocol specific for full-face carbon dioxide laser resurfacing. With a treatment group of 200 patients, we demonstrate that this method of anesthesia is safe and tolerable. Substantial improvement of rhytids, photodamage, and acne scarring was achieved using this protocol. Finally, our results demonstrate an excellent safety profile, with very low rates of hypopigmentation and scarring. METHODS After informed consents were obtained, 200 consecutive fullface carbon dioxide laser-resurfacing procedures were performed using topical anesthesia. The demographics of the patient population were as follows: 193 women, 7 men; 181 for dermatoheliosis and rhytids, 19 for acne scarring. We anesthetized the patients according to the protocol outlined in the Table. For topical anesthesia, a thick layer of EMLA cream was applied as described. Unless contraindicated, patients were given a combination of 5 mg of hydrocodone bitartrate/500 mg of acetaminophen, 5 to 10 mg of diazepam, and 30 to 60 mg of ketorolac tromethamine. The UltraPulse 5000C carbon dioxide laser (Lumenis, Santa Clara, Calif) was used for all of the procedures. The treatments were performed at 300 mj and 60 W. A computer pattern generator was used at the settings of 3 (shape), 9 (size), and 7 (density) feathering laterally to 6 then 5 for the first pass. Anatomic quadrant areas were treated individually. Additional passes with decreased density settings were performed on the same quadrant prior to removing topical anesthetic from other areas in an effort to minimize treatment times and maximize pain control. In most instances, a total of 2 to 3 passes were performed, with the exception of the neck where only a single pass was performed. Patients were monitored closely for pain and comfort. If any patient reported substantial discomfort, additional anesthesia was achieved by regional nerve blocks. Postoperative wound healing was achieved using an open protocol. Patients applied petrolatum without an occlusive dressing and performed dilute vinegar soaks (1 teaspoon per 2 cups of water) every 2 to 3 hours. Patients were given cephalexin or azithromycin (500 mg twice daily or 500 mg daily for 2 weeks), valacyclovir hydrochloride (500 mg twice daily for 2 weeks), and fluconazole (150 mg taken once on the third day after the procedure). After the procedure, patients were evaluated at 1 week, 1 month, 6 months, and 1 year. Photographs were taken prior to treatment and at each of these evaluation times. For histologic studies, skin with and without EMLA underwent carbon dioxide laser treatment as noted above. Biopsy specimens were subsequently fixed, sectioned, and stained with hematoxylin-eosin for further evaluation. RESULTS ANESTHESIA Under our supplemented topical anesthesia protocol, 95% of patients (190/200) did not require additional pain control. Patients were continuously monitored for pain. When pain or discomfort occurred during the procedure, patients were immediately offered additional anesthesia. Whenever possible, a low threshold to add adjuvant anesthesia was maintained. Only 5% of patients (10/200) required nerve blocks (infraorbital, mandibular, and/or supratrochlear). Only 1 patient required localized infiltration of 1% lidocaine. While the vast majority of patients noted minimal discomfort during the first pass, additional passes were associated with somewhat more discomfort, especially in perioral areas. EFFICACY Patients with rhytids, photodamage, and acne scarring were treated in this study. All treated patients had substantial improvement of their conditions. For patients with photodamage and rhytids, representative treatment results are seen in Figure 1. POSTOPERATIVE COURSE Complete reepithelialization occurred at the following rates: 21% (41) by day 6, 89% (178) by day 7, 96% (191) by day 8, and 100% (200) by day 9. In 7 patients, postoperative infections occurred (6 bacterial and 1 herpes simplex virus), all of which resolved with modifications of antimicrobial treatment. Contact dermatitis was seen in 2 patients. IMMEDIATE ADVERSE EFFECTS Immediate adverse effects from using EMLA were not seen. Symptoms and signs of lidocaine toxic effects such as vertigo, metallic taste, tachypnea, tachycardia, and central nervous system depression were not observed. Symptoms and signs of methemoglobinemia, a known complication of EMLA application in children, were not observed. As indicated in the following tabulation, corneal damage from contact with topical anesthesia was not seen: Adverse Effect of EMLA Treatment No. (%) of Patients Signs of lidocaine toxic effects 0 Corneal damage 0 Infection 7 (4) Contact dermatitis 2 (1) Hyperpigmentation 28 (14) Hypopigmentation 1 (1) Scarring
3 A B C D Figure 1. A and C, Photographs representing the skin of 2 of our patients before full-face laser resurfacing using our supplemented topical anesthesia protocol. B and D, Same patients after treatment. Note the improvement of rhytids, photodamage, and dyspigmentation. DELAYED ADVERSE EFFECTS Transient hyperpigmentation was seen in 18% of patients (31 mild, 4 moderate), resolving in 8 to 10 weeks. Hypopigmentation was seen in 1 patient at 12 months. The hypopigmentation involved an area smaller than 8cm 2 along the mandibular line. Scarring was not observed. HISTOLOGIC STUDIES Biopsy specimens were taken from EMLA-treated skin and skin to which EMLA had not been applied in 3 patients. In all 3 patients, the results were similar. The maximum depths of thermal damage were similar where EMLA was applied and where it was not (Figure 2). While skin without EMLA displayed confluent superficial thermal 1281
4 A B Figure 2. Histologic photographs of skin treated with carbon dioxide laser. A, In the skin not treated with the topical eutectic mixture of local anesthetics (EMLA; AstraZeneca Pharmaceuticals LP, Wilmington, Del), note the confluence of superficial thermal damage (bright eosinophilic collagen fibers) and scattered thermal damage in the papillar and reticular dermis. B, The EMLA-treated skin demonstrates less confluence of thermal damage superficially and deeper thermal damge in the papillary and reticular dermis. necrosis, EMLA-treated skin displayed patchy thermal necrosis superficially (Figure 2). Both EMLA-treated skin and skin to which EMLA was not applied demonstrated deeper thermal damage with islands of sparing (Figure 2). COMMENT In this report, we demonstrate the safety and efficacy of topical anesthesia for full-face carbon dioxide resurfacing. This large group of patients tolerated the procedure with minimal pain, and only 5% of patients required adjuvant anesthesia in the form of nerve blocks or local infiltration. While additional patient comfort was achieved by administering the described preprocedure cocktail, neither intravenous sedation nor intravenous analgesics were necessary. Carbon dioxide laser resurfacing ablates tissue in a controlled and predictable fashion. 28 Studies have shown that the UltraPulse 5000 laser used at 450 mj and 5 W ablates 20 to 30 µm of tissue after a single pass, with an additional 20 to 70 µm of thermal coagulation necrosis after 1 to 3 passes. 29 While sufficient anesthesia likely requires anesthetic depths deeper than the sum of ablated and thermally necrotic tissue (approximately 100 µm), this summative depth is the absolute minimum. This minimum depth is far exceeded by the capable depth of anesthesia produced by EMLA. 30 One study showed that anesthesia depths of up to 5 mm could be achieved 2.5 hours after application. 30 Hence, the development of optimized protocols can drastically affect the depth of EMLA efficacy and ultimately its potential utility as a solo agent. In the present study, there were no adverse effects seen with topical EMLA. Previous studies have shown that a 3-hour, 60-g EMLA application (2.5 hours, 60 g used in the present protocol) produced peak blood levels of lidocaine and prilocaine that are 1% and 0.6% of systemic toxic levels, respectively. 31 The most important adverse effect of EMLA is methemoglobinemia, which has mostly been seen in infants None of our patients exhibited any symptoms or signs of cyanosis. Other unusual adverse effects, including contact dermatitis and eye injury, were not observed The vast majority of patients were fully reepithelialized by day 7. Reduction of rhytids, photodamage, and acne scarring was evident and substantial. At this time, it is not known whether the application of EMLA affects the efficacy of carbon dioxide laser resurfacing. Ongoing studies comparing the posttreatment results of hydrated and nonhydrated skin should resolve this issue. Post carbon dioxide resurfacing adverse effects were unusually low with topical anesthesia. Only 1 patient (1%) was found to have hypopigmentation at 1 year. Scarring was not observed. One explanation for the excellent safety profile is the hydrating effect of topical EMLA application. Because the target for the carbon dioxide laser is water, this hydration may be protective. Histologic studies were performed to explore this issue. While EMLAtreated skin and skin without EMLA revealed similar depths of thermal damage, EMLA-treated skin displayed nonconfluent superficial thermal damage. This uneven thermal damage with islands of normal tissue may explain the low rate of scarring and hypopigmentation. In summary, carbon dioxide laser resurfacing can be performed comfortably, effectively, and safely using the supplemented topical anesthesia protocol described here. Preliminary data suggest that the hydrating effects of topical anesthesia may contribute to the low rate or absence of hypopigmentation and scarring. Accepted for publication April 30, Corresponding author: Suzanne L. Kilmer, MD, 3835 J St, Sacramento, CA ( skilmer@skinlasers.com). REFERENCES 1. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a highenergy, pulsed carbon dioxide laser. Dermatol Surg. 1996;22: Alster TS, Garg S. Treatment of facial rhytides with a high-energy pulsed carbon dioxide laser. Plast Reconstr Surg. 1996;98: Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photoaged facial skin. Arch Dermatol. 1996;132: Manuskiatti W, Fitzpatrick RE, Goldman MP. Long-term effectiveness and side effects of carbon dioxide laser resurfacing for photoaged facial skin. J Am Acad Dermatol. 1999;40: Waldorf HA, Kauvar AN, Geronemus RG. Skin resurfacing of fine to deep rhytides using a char-free carbon dioxide laser in 47 patients. Dermatol Surg. 1995; 21:
5 6. Hanke CW. The tumescent facial block: tumescent local anesthesia and nerve block anesthesia for full-face laser resurfacing. Dermatol Surg. 2001;27: Fitzpatrick RE, Williams B, Goldman MP. Preoperative anesthesia and postoperative considerations in laser resurfacing. Semin Cutan Med Surg. 1996;15: Trytko RL, Werschler WP Jr. Total intravenous anesthesia for office-based laser facial resurfacing. Lasers Surg Med. 1999;25: Friedberg BL. Facial laser resurfacing with the propofol-ketamine technique: room air, spontaneous ventilation (RASV) anesthesia. Dermatol Surg. 1999;25: Bing J, McAuliffe MS, Lupton JR. Regional anesthesia with monitored anesthesia care for dermatologic laser surgery. Dermatol Clin. 2002;20: Grekin RC, Auletta MJ. Local anesthesia in dermatologic surgery. J Am Acad Dermatol. 1988;19: Eaton JS, Grekin RC. Regional anesthesia of the face. Dermatol Surg. 2001;27: Yun PL, Tachihara R, Anderson RR. Efficacy of erbium:yttrium-aluminumgarnet laser-assisted delivery of topical anesthetic. J Am Acad Dermatol. 2002; 47: Goodman G. Dermabrasion using tumescent anesthesia. J Dermatol Surg Oncol. 1994;20: Bucalo BD, Mirikitani EJ, Moy RL. Comparison of skin anesthetic effect of liposomal lidocaine, nonliposomal lidocaine, and EMLA using 30-minute application time. Dermatol Surg. 1998;24: Hallen B, Olsson GL, Uppfeldt A. Pain-free venepuncture: effect of timing of application of local anaesthetic cream. Anaesthesia. 1984;39: Maunuksela EL, Korpela R. Double-blind evaluation of a lignocaine-prilocaine cream (EMLA) in children: effect on the pain associated with venous cannulation. Br J Anaesth. 1986;58: Friedman PM, Mafong EA, Friedman ES, Geronemus RG. Topical anesthetics update: EMLA and beyond. Dermatol Surg. 2001;27: Ohlsen L, Englesson S, Evers H. An anaesthetic lidocaine/prilocaine cream (EMLA) for epicutaneous application tested for cutting split skin grafts. Scand J Plast Reconstr Surg. 1985;19: Gupta AK, Sibbald RG. Eutectic lidocaine/prilocaine 5% cream and patch may provide satisfactory analgesia for excisional biopsy or curettage with electrosurgery of cutaneous lesions: a randomized, controlled, parallel group study. J Am Acad Dermatol. 1996;35: Nielsen JC, Arendt-Nielsen L, Bjerring P, Svensson P. The analgesic effect of EMLA cream on facial skin: quantitative evaluation using argon laser stimulation. Acta Derm Venereol. 1992;72: Tan OT, Stafford TJ. EMLA for laser treatment of port-wine stains in children. Lasers Surg Med. 1992;12: Ashinoff R, Geronemus RG. Effect of the topical anesthetic EMLA on the efficacy of pulsed dye laser treatment of port-wine stains. J Dermatol Surg Oncol. 1990; 16: Di Carlo R, Lombardo P, Modugno V, Pastore A. Eutectic mixture of local anesthetics (EMLA): evaluation of the analgesic effectiveness during Nd:YAG laser turbinoplasty [in Italian]. Acta Otorhinolaryngol Ital. 2001;21: Weiss RA, Harrington AC, Pfau RC, Weiss MA, Marwaha S. Periorbital skin resurfacing using high energy erbium:yag laser: results in 50 patients. Lasers Surg Med. 1999;24: Jimenez G, Spencer JM. Erbium:YAG laser resurfacing of the hands, arms, and neck. Dermatol Surg. 1999;25: Jiang SB, Levine VJ, Nehal KS, Baldassano M, Kamino H, Ashinoff RA. Er:YAG laser for the treatment of actinic keratoses. Dermatol Surg. 2000;26: Ross EV, Domankevitz Y, Skrobal M, Anderson RR. Effects of CO2 laser pulse duration in ablation and residual thermal damage: implications for skin resurfacing. Lasers Surg Med. 1996;19: Kauvar AN, Waldorf HA, Geronemus RG. A histopathological comparison of charfree carbon dioxide lasers. Dermatol Surg. 1996;22: Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth. 1990;64: EMLA [package insert]. Wilmington, Del: Astra Zeneca Pharmaceuticals LP; Elsner P, Dummer R. Signs of methaemoglobinaemia after topical application of EMLA cream in an infant with haemangioma. Dermatology. 1997;195: Gourrier E, Leraillez J. Risk of methemoglobinemia after EMLA application in premature infants. Arch Pediatr. 1995;2: Law RM, Halpern S, Martins RF, Reich H, Innanen V, Ohlsson A. Measurement of methemoglobin after EMLA analgesia for newborn circumcision. Biol Neonate. 1996;70: van den Hove J, Decroix J, Tennstedt D, Lachapelle JM. Allergic contact dermatitis from prilocaine, one of the local anaesthetics in EMLA cream. Contact Dermatitis. 1994;30: Thakur BK, Murali MR. EMLA cream-induced allergic contact dermatitis: a role for prilocaine as an immunogen. J Allergy Clin Immunol. 1995;95: Eaglstein NF. Chemical injury to the eye from EMLA cream during erbium laser resurfacing. Dermatol Surg. 1999;25:
Photodamaged skin occurs as a result of its
Plasma Skin Resurfacing for Regeneration of Neck, Chest, and Hands: Investigation of a Novel Device TINA S. ALSTER, MD, AND SAILESH KONDA, BS BACKGROUND Many noninvasive treatments to rejuvenate photodamaged
More informationDEPTH AND DURATION OF SKIN ANALGESIA TO NEEDLE INSERTION AFTER TOPICAL APPLICATION OF EMLA CREAM
British Journal of Anaesthesia 1990; 64: 173-177 DEPTH AND DURATION OF SKIN ANALGESIA TO NEEDLE INSERTION AFTER TOPICAL APPLICATION OF EMLA CREAM P. BJERRING AND L. ARENDT-NIELSEN SUMMARY We have determined
More informationSTUDY. Comparison of Erbium:YAG and Carbon Dioxide Lasers in Resurfacing of Facial Rhytides
STUDY Comparison of Erbium:YAG and Carbon Dioxide Lasers in Resurfacing of Facial Rhytides Khalil A. Khatri, MD; Victor Ross, MD; Joop M. Grevelink, MD, PhD; Cynthia M. Magro, MD; R. Rox Anderson, MD Objective:
More informationIn-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and nm wavelengths.
Histology report No. 02/04-12, date April 2nd, 2012 Page 1 In-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and 10600 nm wavelengths. Paolo
More informationImprovement of Dermatochalasis and Periorbital Rhytides With a High-Energy Pulsed CO 2 Laser: A Retrospective Study
Improvement of Dermatochalasis and Periorbital Rhytides With a High-Energy Pulsed CO 2 Laser: A Retrospective Study TINA S. ALSTER, MD, n AND SUPRIYA G. BELLEW, MD w n Washington Institute of Dermatologic
More informationAblative Skin Resurfacing With a Novel Microablative CO 2 Laser
FEBRUARY 2009 138 COPYRIGHT 2009 ORIGINAL ARTICLES JOURNAL OF DRUGS IN DERMATOLOGY Ablative Skin Resurfacing With a Novel Microablative CO 2 Laser a b e ABSTRACT Carbon dioxide (CO 2 ) laser skin resurfacing
More informationTreatment of periorbital wrinkles with 1,550 and 1,565 nm Er:Glass fractional photothermolysis lasers: A simultaneous split-face trial
Treatment of periorbital wrinkles with 1,550 and 1,565 nm Er:Glass fractional photothermolysis lasers: A simultaneous split-face trial Jin Young Jung Department of Medicine The Graduate School, Yonsei
More informationCitation for published version (APA): van Drooge, A. M. (2014). Improvement of disfiguring skin conditions by laser therapy
UvA-DARE (Digital Academic Repository) Improvement of disfiguring skin conditions by laser therapy van Drooge, A.M. Link to publication Citation for published version (APA): van Drooge, A. M. (2014). Improvement
More informationACNE IS A COMMON DISORder,
ORIGINAL ARTICLE Evaluation of Acne Scar Treatment With a 1450-nm Midinfrared Laser and 30% Trichloroacetic Acid Peels Paul J. Carniol, MD; Jyothi Vynatheya; Eric Carniol Objective: To evaluate the efficacy
More informationNONABLATIVE RESURFACING
`AESTHETIC LASER SURGERY 0094-1298/00 $15.00 +.00 NONABLATIVE RESURFACING David J. Goldberg, MD TYPES OF LASERS AND THEIR DIFFERENCES Pulsed char-free CO2 laser skin resurfacing has provided a method of
More informationConventional ablative carbon dioxide (CO 2 ) and
Lower-Fluence, Higher-Density versus Higher-Fluence, Lower-Density Treatment with a 10,600-nm Carbon Dioxide Fractional Laser System: A Split-Face, Evaluator-Blinded Study JIN YOUNG JUNG, MD, JU HEE LEE,
More informationAdverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: A study of 500 patients
THERAPY Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: A study of 500 patients Vi&i J. Levine, MD, and Roy G. Geronemus, MD
More informationClinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System
Plastic Surgery International Volume 00, Article ID 87448, 4 pages doi:0.55/00/87448 Clinical Study Treatment of Mesh Skin Grafted Scars Using a Plasma Skin Regeneration System Takamitsu Higashimori, Taro
More informationOBSERVATION. Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser
OBSERVATION Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser Tatyana R. Humphreys, MD; Rajwant Malhotra, MD; Mark J. Scharf,
More informationComparison of Four Carbon Dioxide Resurfacing Lasers
Comparison of Four Carbon Dioxide Resurfacing Lasers A CLINICAL AND HISTOPATHOLOGIC EVALUATION Tina S. Alster, MD, Christopher A. Nanni, MD, and Carmen M. Williams, MD Washington Institute of Dermatologic
More informationNO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD
NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD KEY POINTS Hispanics/Latinos are the fastest growing segment of the skin of color population Use
More informationIn Vivo Histological Evaluation of a Novel YSGG Ablative Fractional Device for Cutaneous Remodeling
In Vivo Histological Evaluation of a Novel YSGG Ablative Fractional Device for Cutaneous Remodeling Walfre Franco, PhD a1, Brian D. Zelickson, MD b, Victor E. Ross, MD c a Cutera Inc., Brisbane, CA b Abbott
More informationNon-ablative Acne Scar Reduction with a Short-Pulsed 1064-nm Nd:YAG Laser a Pilot Study
Non-ablative Acne Scar Reduction with a Short-Pulsed 1064-nm Nd:YAG Laser a Pilot Study Graeme Lipper, MD; Maritza Perez, MD Advanced Dermcare, Danbury, CT Presented by Graeme Lipper, MD at the American
More informationSTUDY. Treatment of Atrophic Facial Acne Scars With the 1064-nm Q-Switched Nd:YAG Laser
STUDY Treatment of Atrophic Facial Acne Scars With the 1064-nm Q-Switched Nd:YAG Laser Six-Month Study Paul M. Friedman, MD; Ming H. Jih, MD, PhD; Greg R. Skover, PhD; Greg S. Payonk, PhD; Arash Kimyai-Asadi,
More informationIndex. B Bacterial infections, prevention of, in laser therapy, 183, 208, 209, 224, 290. Note: Page numbers of article titles are in boldface type.
Oral Maxillofacial Surg Clin N Am 16 (2004) 301 307 Index Note: Page numbers of article titles are in boldface type. A Acne, laser skin resurfacing and, 295 296 Actinic keratoses, carbon dioxide laser
More informationNew Medicines Profile
New Medicines Profile August 2008 Issue. 08/07 Lidocaine 70mg/tetracaine 70mg medicated plaster (Rapydan ) Concise evaluated information to support the managed entry of new medicines in the NHS Summary
More informationIN THE PAST decade, laser skin resurfacing
STUDY Evaluation of a Silicone Occlusive Dressing After Laser Skin Resurfacing R. Sonia Batra, MD, MSc, MPH; Richard J. Ort, MD; Carolyn Jacob, MD; Lori Hobbs, MD; Kenneth A. Arndt, MD; Jeffrey S. Dover,
More informationA novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: A pilot study
Journal of Cosmetic and Laser Therapy, 2010; 12: 208 212 ORIGINAL ARTICLE A novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: A pilot study SHLOMIT
More informationMulti-Application Platform. Summary of Peer-reviewed Articles for Various Clinical Indications April 2016
Multi-Application Platform Summary of Peer-reviewed Articles for Various Clinical Indications April 2016 Various Clinical Indications Atrophic acne scars and acne Photo-aged skin, pigmentation & hyperpigmentation
More informationXF Microlens Optic and XD Microlens Compression Optic for Non-Ablative Fractional Skin Treatment with the Palomar Icon System
Optic and XD Microlens Compression Optic for Non-Ablative Fractional Skin Treatment with the Palomar Icon System Sean Doherty, M.D., 1 Brooke Seckel, M.D., 1 James Childs Ph.D., 2 David Tabatadze Ph.D.,
More information1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study
1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study KRISTEL D. POLDER, MD, y APRIL HARRISON, PA-C, y LEIGH ELLEN EUBANKS, MD, y AND SUZANNE BRUCE, MD y BACKGROUND
More informationNonablative Infrared Skin Tightening in Type IV to V Asian Skin: A Prospective Clinical Study
Nonablative Infrared Skin Tightening in Type IV to V Asian Skin: A Prospective Clinical Study SZE-HON CHUA, FRCP (EDIN), POR ANG, MRCP (UK), y LAWRENCE S. W. KHOO, MRCP (UK), y AND CHEE-LEOK GOH, FRCP
More informationTo Debride or Not to Debride? That Is the Question: Rethinking Char Removal in Ablative CO 2 Laser Skin Resurfacing
To Debride or Not to Debride? That Is the Question: Rethinking Char Removal in Ablative CO 2 Laser Skin Resurfacing JOE NIAMTU III, DMD BACKGROUND The treatment standard for laser skin resurfacing (LSR)
More informationEfficacy and safety of ablative fractional carbon dioxide laser for acne scars
Original Article Efficacy and safety of ablative fractional carbon dioxide laser for acne scars Tahir Jamil Ahmad*, Farhana Muzaffar**, Haroon Nabi *, Sarmad Malik*, Ayesha Noreen*, Rabiya Hayat *Department
More informationFractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses COS DERM
Case Report Fractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses LindaSusan Marcus, MD; Neal Carlin, BS; Robert Carlin, BS, MA It is important to realize that
More informationLASER TREATMENT PEARLS FOR PHOTO-REJUVENATION
LASER TREATMENT PEARLS FOR PHOTO-REJUVENATION Suzanne L. Kilmer, M.D. Director, Laser & Skin Surgery Center of Northern California Clinical Professor, Department of Dermatology University of California,
More informationidentifying & treating Structural Skin Damage
identifying & treating Structural Skin Damage How Collagen and Elastin are Formed The dermis is comprised of three layers: the papillary dermis, the reticular dermis, and the subcutaneous dermis. The process
More informationDual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background
Dual wavelength (1540nm + 10600 nm) mixed technology for fractional resurfacing in skin rejuvenation Dr. Paolo Sbano, M.D. Specialist in Dermatology and Venereology Department of Dermatology of Belcolle
More informationEfficacy of minimally invasive nonthermal laser-induced optical breakdown technology for skin rejuvenation
Lasers Med Sci (20) 28:95 940 DOI 0.007/s00-02-79-z ORIGINAL ARTICLE Efficacy of minimally invasive nonthermal laser-induced optical breakdown technology for skin rejuvenation Louis Habbema & Rieko Verhagen
More informationReview paper Laser Skin Resurfacing
Review paper Laser Skin Resurfacing L. Bijnens, E. Oost Submitted for publication Email: info@memssa.co.za Telephone: (+27 71) 285-4801 Abstract Cosmetic surgery has substantially gained in popularity
More informationSTUDY. Comparative Clinical Trial of 2 Carbon Dioxide Resurfacing Lasers With Varying Pulse Durations
Comparative Clinical Trial of 2 Carbon Dioxide Resurfacing Lasers With Varying Pulse Durations 100 Microseconds vs 1 Millisecond STUDY Daniella Duke, MD, MPH; Khalil Khatri, MD; Joop M. Grevelink, MD,
More informationHybrid Energy TM Technology
Surgen Hybrid Energy - A novel Micro-Needles for Skin Treatment Alex Levenberg, M.D. 1, Cruzira T Salazar, M.D. 2, Marie Christine Branchet, PhD 3, Sylvie Boisnic, M.D. 3 1 Physicians Center, Plastic Surgery
More informationLaser Treatment of Leg Veins
Laser Treatment of Leg Veins Updated: Sep 17, 2015 Author: Mitchel P Goldman, MD; Chief Editor: Dirk M Elston, MD more... Overview Background Public interest in laser and light treatment of leg veins is
More informationEmla (lidocaine 2.5% and prilocaine 2.5%), Lidocaine Topical 5%, Pliaglis Cream (lidocaine 7% and tetracaine 7%), Tetravex Gel (tetracaine 2%)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Lidocaine Topicals Page: 1 of 5 Last Review Date: September 20, 2018 Lidocaine Topicals Description
More informationTopical EMLA Cream as a Pretreatment for Facial Lacerations
Topical EMLA Cream as a Pretreatment for Facial Lacerations Original Article Sung Woo Park, Tae Suk Oh, Jong Woo Choi, Jin Sup Eom, Joon Pio Hong, Kyung S Koh, Taik Jong Lee, Eun Key Kim Department of
More informationName of Policy: Pulsed Dye Laser Treatment of Recalcitrant Verrucae
Name of Policy: Pulsed Dye Laser Treatment of Recalcitrant Verrucae Policy #: 187 Latest Review Date: July 2010 Category: Surgery Policy Grade: Active Policy but no longer scheduled for regular literature
More informationSTUDY. A Comparison of 3 Lasers and Liquid Nitrogen in the Treatment of Solar Lentigines
STUDY A Comparison of 3 s and Liquid Nitrogen in the Treatment of Solar Lentigines A Randomized, Controlled, Comparative Trial Michael M. Todd, MD; Tena M. Rallis, MD; John W. Gerwels, MD; Tissa R. Hata,
More informationEMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin Injection A Randomized, Double-Blind, Placebo-Controlled Trial
Bahmani-Kashkouli et al EMLA Cream and Botulinum Toxin Iranian Journal of Ophthalmology - Volume 19, Number 4, 2007 EMLA Cream Application without Occlusive Dressing before Upper Facial Botulinum Toxin
More informationUltraPulse. UltraPulse. Physician Recommended Treatment Parameters. ActiveFX DeepFX TotalFX SCAAR FX
UltraPulse UltraPulse TotalFX Physician Recommended Treatment Parameters Updated JUNE 2012 2012 Treatment Depths Treatment Depths The depth of ablation is directly correlated to the energy levels. The
More informationCLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS
CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS BACKGROUND Efforts to improve fractional ablative laser systems have led to the development of
More informationSPECIAL TOPIC. AboutSkin Dermatology & DermSurgery, Greenwood Village, CO b. The Aesthetic Clinique, Destin, FL c
November 2016 611 Volume 15 Issue 11 Copyright 2016 ORIGINAL ARTICLES SPECIAL TOPIC Multi-Center Pilot Study to Evaluate the Safety Profile of High Energy Fractionated Radiofrequency With Insulated Microneedles
More informationcombining Fractional RF and Superficial RF
combining Fractional RF Microneedling and Superficial RF Resurfacing Marge Uibu discusses combination treatments with a microneedling device for dermal rejuvenation, as well as the treatment of acne and
More informationClinical Efficacy and Statistical Evaluation of INTRAcel Treatment
Unique technology of Fractional RF Micro-needles TM 1 Clinical Efficacy and Statistical Evaluation of INTRAcel Treatment Takashi Takahashi, M.D. Dermatologist Takahashi Clinic Shibuya, Tokyo, Japan BACKGROUND:
More informationFRACTIONAL PHOTOTHERMOLYsis
ORIGINAL ARTICLE 1550-nm Nonablative Laser Resurfacing for Facial Surgical Scars Annette M. Pham, MD; Ryan M. Greene, MD, PhD; Heather Woolery-Lloyd, MD; Joely Kaufman, MD; Lisa D. Grunebaum, MD Objective:
More informationEFFICACY OF EUTECTIC MIXTURE OF LIGNOCAINE AND PRILOCAINE IN CLOSED REDUCTION OF NASAL FRACTURES
Acta Biomedica Scientia e - ISSN - 2348-2168 Print ISSN - 2348-215X www.mcmed.us/journal/abs Research Article EFFICACY OF EUTECTIC MIXTURE OF LIGNOCAINE AND PRILOCAINE IN CLOSED REDUCTION OF NASAL FRACTURES
More informationTopical Local Anaesthesia
Topical Local Anaesthesia Comfort Kids Program 2017 Topical Local Anaesthesia (LA) How does topical LA cream works Misconceptions Cautions Preparation Application Alternatives Dosage Documentation Basic
More informationArisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego
1 What s New in Skin Tightening? Arisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego 2 Disclosures BTL, InMode, Sciton Equipment
More informationLASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD
LASERS: CAN THEY TREAT SPIDER VEINS? Steven E. Zimmet, MD No conflicts of interest DISCLOSURES YES! WHY USE LASERS FOR LEG VEINS? Patient s Perception Less Painful Newer technology Must be better Needle
More informationComparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars
Original Article Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars Neerja Puri Consultant Dermatologist, Punjab Health Systems Corporation,
More informationCombination Surgical Lifting with Ablative Laser Skin Resurfacing of Facial Skin: A Retrospective Analysis
ORIGINAL ARTICLE Combination Surgical Lifting with Ablative Laser Skin Resurfacing of Facial Skin: A Retrospective Analysis TINA S. ALSTER, MD, n SEEMA N. DOSHI, MD, n AND STEVEN B. HOPPING, MD w n Washington
More informationINTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON
22 COPYRIGHT 2007 INTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON Martin Braun MD Vancouver Laser & Skin Care Centre Inc, Vancouver,
More informationFrequently Asked Questions
1112:V15:05:PB1540 Frequently Asked Questions For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory Dear Doctor, Warm regards from Cipla Xterna!!! We, at Cipla Xterna, a dedicated
More informationspecial report special report MULTIPLE CONDITIONS EFFECTIVELY TREATED WITH THE PLASMA SKIN REGENERATION SYSTEM
Portrait PSR Technology MULTIPLE CONDITIONS EFFECTIVELY TREATED WITH THE PLASMA SKIN REGENERATION SYSTEM By Christopher B. Zachary, M.D. atnt The impact of the economic crash in 2008 was felt by many of
More informationReports on Scientific Meeting
Hong Kong J. Dermatol. Venereol. (2005) 13, 102-106 63rd Annual Meeting, American Academy of Dermatology Reported by LS Chiu Date: 22 February, 2005 Venue: New Orleans, Louisiana, USA Organiser: American
More informationSTUDY. Connective Tissue Remodeling Induced by Carbon Dioxide Laser Resurfacing of Photodamaged Human Skin
STUDY Connective Tissue Remodeling Induced by Carbon Dioxide Laser Resurfacing of Photodamaged Human Skin Jeffrey S. Orringer, MD; Sewon Kang, MD; Timothy M. Johnson, MD; Darius J. Karimipour, MD; Ted
More informationStudy of the Effect of PDL Treatment of Recalcitrant Plantar Warts
ORIGINAL ARTICLE Study of the Effect of PDL Treatment of Recalcitrant Plantar Warts Ahmed Al-Mutairi, MD, Muhammad Elkashlan, MD Department of Dermatology, Ahmadi Hospital, Kuwait ABSTRACT Forty patients
More informationAnesthesia and Analgesia
Chapter 4 Anesthesia and Analgesia M. de Maio 4 Contents 4.1 Introduction................ 23 4.2 Preoperative Evaluation......... 23 4.3 Local Anesthesia............. 24 4.4 Topical Anesthesia............
More informationHands-on: Lasers. NonAblative Rejuvenation
Hands-on: Lasers NonAblative Rejuvenation Anthony M. Rossi, MD Assistant Attending Memorial Sloan Kettering Cancer Center Assistant Professor Weill Cornell Medical College DISCLOSURE OF RELEVANT RELATIONSHIPS
More informationSTUDY. Laser-Mediated Photodynamic Therapy of Actinic Keratoses
STUDY Laser-Mediated Photodynamic Therapy of Actinic Keratoses Macrene R. Alexiades-Armenakas, MD, PhD; Roy G. Geronemus, MD Objective: To assess the safety and efficacy of the longpulsed pulsed dye laser
More informationDo Not Copy. Penalties Apply
August 2009 723 Volume 8 Issue 8 Copyright 2009 Original Articles Journal of Drugs in Dermatology Ablative Fractionated CO 2 Laser Resurfacing for the Neck: Prospective Study and Review of the Literature
More informationClinical Articles. Peer Reviewed Articles
Clinical Articles Peer Reviewed Articles System Used Acne Scars Evaluation of a Novel Fractional Resurfacing Device for Treatment of Acne Scarring. Walgrave, S., et al. (2009). Lasers in Surgery and Medicine,41(2),
More informationDO NOT DUPLICATE. Negative pressure wound therapy (NPWT) has revolutionized the
Original research WOUNDS 2013;25(4):89 93 From the Aesthetic and Plastic Surgery Institute, University of California Irvine, Orange, CA and Long Beach Memorial Medical Center, Long Beach, CA Address correspondence
More informationDermatologic Therapy 2000 Blackwell Science Ltd. Volume 13(1) 2000 pp Laser revision of scars and striae [The Use Of Lasers In Dermatology]
Dermatologic Therapy 2000 Blackwell Science Ltd. Volume 13(1) 2000 pp 50-59 Laser revision of scars and striae [The Use Of Lasers In Dermatology] Groover, Ivy J.; Alster, Tina S. PayPerView Account PayPerView
More informationPresentation Product & clinics
Presentation Product & clinics Design What s Long Pulse Nd:YAG? medium YAG (Yuttrium Aluminum Garnet : Y 3 Al 5 O 12 ) + Nd 3+ The Wavelength Penetrates All kind of Hair removal Each laser possesses specific
More informationMING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1)
Curettage prior to Mohs Micrographic Surgery for Previously Biopsied Nonmelanoma Skin Cancers: What Are We Curetting? Retrospective, Prospective, and Comparative Study MING H. JIH, MD,PHD, PAUL M. FRIEDMAN,
More informationAL-AZHAR ASSIUT MEDICAL JOURNAL
TOPICAL LIDOCAINE-PRILOCAINE CREAM (EMLA) VERSUS MEPIVACAINE INFILTRATION FOR REDUCING PAIN DURING REPAIR OF MEDIOLATERAL EPISIOTOMY AFTER SPONTANEOUS VAGINAL DELIVERY Hossam M Abdelnaby and Ahmed Mahmoud
More informationJOHN Z. S. CHEN, MD, n MACRENE R. ALEXIADES-ARMENAKAS, MD,PHD, n LEONARD J. BERNSTEIN, MD, n LAURIE G. JACOBSON, MD, n PAUL M.
Two Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the S-Caine Peel for Induction of Local Anesthesia Before Long-Pulsed Nd:YAG Laser Therapy for Leg Veins JOHN Z. S. CHEN, MD, n MACRENE
More informationAnnex II. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation
Annex II Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation 6 Scientific conclusions Overall summary of the scientific evaluation of EMLA cream and associated
More informationEffects of Skin Temperature on Lesion Size in Fractional Photothermolysis
Lasers in Surgery and Medicine 39:14 18 (2007) Effects of Skin Temperature on Lesion Size in Fractional Photothermolysis Hans Laubach, MD, 1 Henry H. Chan, MD, 2 Francisca Rius, PhD, 1,3 R. Rox Anderson,
More informationEvaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments
Evaluating facial pores and skin texture after low-energy nonablative fractional 1440-nm laser treatments Nazanin Saedi, MD, a Kathleen Petrell, BS, a Kenneth Arndt, MD, a,b,c and Jeffrey Dover, MD, FRCPC
More informationSplit-Face Study Using a 1,927-nm Thulium Fiber Fractional Laser to Treat Photoaging and Melasma in Asian Skin
ORIGINAL ARTICLES Split-Face Study Using a 1,927-nm Thulium Fiber Fractional Laser to Treat Photoaging and Melasma in Asian Skin HYUNG MIN LEE, MD,* 1 SIK HAW, MD, 1 JAE KYUNG KIM, MD,* SUNG EUN CHANG,
More informationAvailable online at Vol. 07, No. 02, pp , February, 2018 RESEARCH ARTICLE
z Available online at http://www.ijcrls.com International Journal of Current Research in Life Sciences Vol. 07, No. 02, pp.1139-1143, February, 2018 ISSN: 2319-9490 RESEARCH ARTICLE THE TREATMENT OF DILATED
More informationFEB-2015 ISSUE. Dr. David Pudukadan
FEB-2015 ISSUE Skin Tightening, Body Contouring, Fractional Skin Resurfacing and Microneedles Skin Remodeling using an innovative 3DEEP, FDA approved, Multisource Phase Controlled RF Device Dr. David Pudukadan
More informationSkin Deep. Agenda. Burns Wounds Debridement Evaluation and Management Services. Presented by: Mike Strong, SFM The Work Comp Experts.
Presented by: Mike Strong, SFM The Work Comp Experts Agenda Wounds Debridement Evaluation and Management Services 2 1 Types of First Degree Second Degree Third Degree Rule of 9 Adults Infants Burn Coding
More informationLocal Anesthetics in Cosmetic Dermatology. Peter W. Hashim, MD, MHS; John K. Nia, MD; Mark Taliercio, BS; Gary Goldenberg, MD
COSMETIC DERMATOLOGY Local Anesthetics in Peter W. Hashim, MD, MHS; John K. Nia, MD; Mark Taliercio, BS; Gary Goldenberg, MD PRACTICE POINTS The proper delivery of local anesthesia is integral to successful
More informationProFractional. ProFractional Therapy. Tunable Fractional Solution. Advanced Fractional Aesthetic Laser Surgery
ProFractional-XC ProFractional ProFractional Therapy Tunable Fractional Solution Advanced Fractional Aesthetic Laser Surgery ProFractional-XC is taking fractionated resurfacing to the next level. Todd
More informationMicroneedling Therapy in Atrophic Facial Scars: An Objective Assessment
ORIGINAL ARTICLE Microneedling Therapy in Atrophic Facial Scars: An Objective Assessment Background: Atrophic facial scars are always a challenge to treat, especially the ones that are deep-seated and/or
More informationSTUDY. Topical 5-Aminolevulinic Acid Combined With Intense Pulsed Light in the Treatment of Photoaging
STUDY Topical 5-Aminolevulinic Acid Combined With Intense Pulsed Light in the Treatment of Photoaging Jeffrey S. Dover, MD, FRCPC; Ashish C. Bhatia, MD; Brigitte Stewart; Kenneth A. Arndt, MD Background:
More informationEvaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy
Evaluation of lidocaine as an analgesic when added to hypertonic saline for sclerotherapy Rizwan H. Bukhari, MD, Joann M. Lohr, MD, Douglas S. Paget, MD, Andrew T. Hearn, MD, and Robert D. Cranley, MD,
More informationCorrespondence should be addressed to Pratik Gahalaut;
ISRN Dermatology, Article ID 743027, 5 pages http://dx.doi.org/10.1155/2014/743027 Clinical Study Comparison of Topical Anesthetics for Radiofrequency Ablation of Achrocordons: Eutectic Mixture of Lignocaine/Prilocaine
More informationOriginal Policy Date
MP 7.01.42 Laser-Assisted Tonsillectomy Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy
More informationEx Vivo Histological Characterization of a Novel Ablative Fractional Resurfacing Device
Lasers in Surgery and Medicine 39:87 95 (2007) Ex Vivo Histological Characterization of a Novel Ablative Fractional Resurfacing Device Basil M. Hantash, MD, PhD, 1,2 Vikramaditya P. Bedi, MS, 2 Kin Foong
More informationCombining Confluent and Fractionally Ablative Modalities of a Novel 2790nm YSGG Laser for Facial Resurfacing
Lasers in Surgery and Medicine 43:273 282 (2011) Combining Confluent and Fractionally Ablative Modalities of a Novel 2790nm YSGG Laser for Facial Resurfacing Girish S. Munavalli, MD, MHS, 1,2 Ayse Turley,
More informationAcute Pain Management in Children an update
Acute Pain Management in Children an update Frances W. Craig, MD FAAP East Tennessee Children s Hospital Overview Some pain basics Why we don t treat pain and why we should Non pharmacologic approaches
More informationPalomar Icon 1540 Fractional Laser. Fractional Non-Ablative Skin Resurfacing
Palomar Icon 1540 Fractional Laser Fractional Non-Ablative Skin Resurfacing Palomar Icon Aesthetic System 2 Any treatment guidelines or parameters contained herein are intended for reference only and should
More informationNOVEL MULTI-SOURCE PHASE-CONTROLLED RADIOFREQUENCY TECHNOLOGY FOR NON- ABLATIVE AND MICRO-ABLATIVE TREATMENT OF WRINKLES, LAX SKIN AND ACNE SCARS
available at www.jstage.jst.go.jp/browse/islsm REVIEW ARTICLES NOVEL MULTI-SOURCE PHASE-CONTROLLED RADIOFREQUENCY TECHNOLOGY FOR NON- ABLATIVE AND MICRO-ABLATIVE TREATMENT OF WRINKLES, LAX SKIN AND ACNE
More informationCitation for published version (APA): van Drooge, A. M. (2014). Improvement of disfiguring skin conditions by laser therapy
UvA-DARE (Digital Academic Repository) Improvement of disfiguring skin conditions by laser therapy van Drooge, A.M. Link to publication Citation for published version (APA): van Drooge, A. M. (201). Improvement
More informationKLERESCA ACNE TREATMENT NO MORE HIDING. Using fluorescent light energy to treat your acne
KLERESCA ACNE TREATMENT NO MORE HIDING Using fluorescent light energy to treat your acne Introducing a new technology that boosts your own healing mechanisms 1-8 Non-invasive treatment Using fluorescent
More informationF ORUM. Laser-Assisted Breast Reduction: A Safe and Effective Alternative. A Study of 367 Patients
Laser-Assisted Breast Reduction: A Safe and Effective Alternative. A Study of 367 Patients W. Grant Stevens, MD; Robert Cohen, MD; Steven A. Schantz, MD; David A. Stoker, MD; Steven D. Vath, MD; Elliot
More informationPulsed dye laser therapy for viral warts
British Journal of Plastic Surgery (1999), 52, 554 558 1999 The British Association of Plastic Surgeons Pulsed dye laser therapy for viral warts J. Kenton-Smith and S. T. Tan* Wellington Regional Plastic
More informationAdvances in Lasers for Skin of Color
Review Advances in Lasers for Skin of Color Heather Woolery-Lloyd, MD; Mohamed L. Elsaie, MD, MBA The popularity of cutaneous laser surgery has soared; however, the use of lasers in patients with skin
More informationCutaneous CO2 Laser Resurfacing Infection Rate With and Without Prophylactic Anti biotics
Cutaneous CO2 Laser Resurfacing Infection Rate With and Without Prophylactic Anti biotics SUNILA WALIA AND TINA S. ALSTER Washington Institute of Dermatologic Laser Surgery Washington D.C. BACKGROUND.
More informationThe use of light as a medical treatment has SPECIAL TOPIC. Fractional Photothermolysis for Skin Rejuvenation.
SPECIAL TOPIC Fractional Photothermolysis for Skin Rejuvenation Steven R. Cohen, M.D. Cory Henssler, R.N. Jennifer Johnston, R.N. La Jolla, Calif.; and San Diego, Calif. Background: Fractional photothermolysis
More informationMCL 30. MCL 30 Dermablate Fractional Er:YAG (with MICROSPOT EXTENSION SET) EN 1
MCL 30 MCL 30 Dermablate Fractional Er:YAG (with MICROSPOT EXTENSION SET) 1 The third generation of the Dermablate series MCL 29 Dermablate Dermablate D1 MCL 30 Dermablate MCL29, the first Er:YAG laser
More informationComparative study of percutaneous collagen induction therapy and dermabrasion on post acne scars
Original Research Article DOI: 10.18231/2455-6769.2017.0019 Comparative study of percutaneous collagen induction therapy and dermabrasion on post acne scars Nithya Priyadharshini S 1, Geetha K 2,* 1,2
More information